Both researchers are located in Max Rady College of Medicine departments and are advised by Dr. Annette Schultz of the College of Nursing.

Dr. Anna Chudyk, a postdoctoral fellow in the department of family medicine, and Amanda Fowler-Woods, a PhD candidate in community health sciences, are both first-time recipients of the SPOR national training fellowship.

Both said they are honoured to have their work recognized by CIHR and receive their fellowships, which were created to support development of leaders in the field of patient-oriented research.

Dr. Anna Chudyk

Chudyk was awarded $70,000 per year plus a research stipend for three years for her work on the theory and application of patient-oriented research, which she is leading in collaboration with patients, the departments of family medicine and surgery, College of Nursing, Faculty of Kinesiology and Recreation Management and St. Boniface Hospital Research Centre researchers.

“My current projects are focused on developing a deep theoretical understanding of patient-oriented research and applying this knowledge to enhance capacity for patient-oriented research, both within St. Boniface Hospital Research Centre and the broader Canadian patient-oriented research community,” she said.

Chudyk began her research career by obtaining a master’s degree in epidemiology and biostatistics from the University of Western Ontario. While at the University of British Columbia, she found an interest in applying her research skills to helping people in the community through participatory research, which brought her to UM last year.

“I truly believe that those affected by a problem should be actively involved in the generation of solutions to it, and that individuals’ reflections on their first-hand experiences are essential to effecting individual and social change,” she said.

While this is her first SPOR fellowship, her master’s and PhD studies were also supported by national CIHR scholarships through the Frederick Banting and Charles Best Canada Graduate Scholarship and Vanier Canada Graduate scholarship programs.

Amanda Fowler-Woods

Fowler-Woods received $50,000 per year for two years for her Indigenous health research. A two-time UM alumna who works regularly with Ongomiizwin – Indigenous Institute of Health and Healing, she said this is the first time she’s received CIHR funding for work that she leads, although she has worked on several other CIHR-funded projects.

“This fellowship will allow me two years to finish my dissertation research project, which is part of a larger project initiated through Shared Health which involves the development of a system for the collection of racial and ethnic identifier data within the Manitoba health-care system.  This is something we don’t do consistently in Canada, but is being done in other countries, like the U.S., New Zealand, Australia and the U.K.,” she said.

She said the award will also help with her work at UM’s George & Fay Yee Centre for Healthcare Innovation, where she is working to incorporate Indigenous health perspectives throughout its various platforms.

“As an Indigenous researcher, it has always been important to me that my work is focused on the health of Indigenous peoples,” said Fowler-Woods, who grew up in Thunder Bay, Ont. “I have a very strong connection to my Ojibwe culture and I feel very fortunate that this fellowship will allow me to continue my work in this area.”  

C4T (Canadian Childhood Cannabinoid Clinical Trials) is an academic-led research team comprising parents, doctors, nurses and scientists. Their goal is to “move cannabinoid use from the era of anecdote to evidence to treat health concerns in children.” (https://www.c4trials.org/)

Dr. Lauren Kelly

The scientific director of C4T, and nominated principal applicant, Dr. Lauren Kelly, is a pharmacologist, assistant professor in the department of pediatrics & child health and community health sciences in the Max Rady College of Medicine, clinical trialist at the George & Fay Yee Centre for Healthcare Innovation, and research scientist at the Children’s Hospital Research Institute of Manitoba.

Kelly says that the use of cannabis by pediatric cancer patients to treat symptoms like pain, nausea and anxiety is increasing. She points to a 2017 survey by the Canadian Pediatric Surveillance Program of 1500 pediatricians, which found that 50% of pediatricians manage at least one child using cannabis for medical purposes and 22% manage five or more.

Since there are currently no pharmaceutical grade cannabis products approved for use in children, cannabis is being obtained from various sources including black market websites.

“The need for high-quality evidence is paramount to ensure the safe use of cannabis products by children,” says Kelly. “It is time to focus on obtaining rigorous evidence and develop the clinical trials needed to inform safe selection and dosing of cannabis products in children where the risks and benefits are appropriately balanced.”

The team will gather information through several different means. They will survey physicians, nurses, pharmacists, patients and parents to gather information on which cannabis products are currently being used for symptom management to give them a better idea of which products have the best safety profile.

A parent-led group will conduct qualitative interviews that were designed by the researchers with families of children with cancer to help better understand access to medical cannabis, physician support and reasons for cannabis use.

A registry across five provinces will be established to collect clinical information on use of cannabis from pediatricians who manage children with cancer and other conditions to evaluate the safety, pharmacodynamics (the effect of drugs on the body) and pharmacokinetics (how the body processes the drug) of cannabis use in children.

Additionally, the team will conduct an open-label dose finding study on a cannabis health product for symptom management in children with cancer, collecting samples from patients using cannabis at several hospitals across Canada.

All of this information will be compiled into a resource hub for the public and families, containing up-to-date evidence on cannabis use for medical purposes in children, either for during active cancer treatment or for symptom management post-treatment. The hub will also contain communications tips for parents and health-care professionals on how to approach the subject with each other.

Kelly says that parents are looking for reliable information and she hopes that this study will help fill in some of those gaps.

“It’s a lot about learning from the parents and where they’re getting information. Many patients have had a less than ideal experience trying to use medical cannabis in hospitals. They want to know who they can trust and how we can build this trust,” she says.

The end goal will be to develop an active clinical trial and facilitate drug development for a regulated pharmaceutical grade cannabis product approved for use in children with cancer, for which there are currently none available.

For more information on the project please visit: https://www.c4trials.org/

The interdisciplinary team is one of only four research groups in Canada to receive funding from CIHR’s Human Immunology Research Teams grant, an initiative to study autoimmune diseases with the goal of improving the knowledge of the human immune system.

“We’re delighted to receive this CIHR funding, but we also recognize the challenges ahead in undertaking such an interdisciplinary project,” said Dr. Hani El-Gabalawy, professor of medicine and immunology and Endowed Rheumatology Research Chair, Max Rady College of Medicine.

The project, titled Prediction and prevention of rheumatoid arthritis in First Nations People, has three aims. The first aim is to improve biomarkers in predicting whether someone will develop rheumatoid arthritis.

El-Gabalawy, the project’s principal investigator, said that rheumatoid arthritis “starts before it starts.” Meaning that before someone develops sore, stiff or swollen joints, and a diagnosis can be made by a doctor, the person has biomarkers in their blood that show their immune system isn’t functioning properly, he said.

The biomarker could be present for up to 10 years before the person develops any symptoms, El-Gabalawy said. However, not everyone who has these biomarkers will develop rheumatoid arthritis. So part of what the research team is trying to do with this first aim is to find better ways of predicting who will develop rheumatoid arthritis.

The project builds on team members’ previous research that showed that rheumatoid arthritis is very common in some First Nations families. El-Gabalawy said that the disease can be particularly damaging and resistant in First Nations people.

Aim two of the project will be a randomized clinical trial in First Nations communities to see whether the combination of turmeric, omega-3 and vitamin D can reduce the risk of rheumatoid arthritis based on biomarkers developed through the first aim. In support of this approach, team members’ previous research showed that this combination of supplements helped prevent inflammatory arthritis in mice.

Co-investigator Dr. Dylan Mackay, an assistant professor in the department of community health sciences and a clinical trialist with the George & Fay Yee Centre for Healthcare Innovation, said that if the results of the trial are favourable, it could mean that treatment costs could be reduced or avoided with the trio of affordable supplements.

“Some of the modern rheumatoid treatments are incredibly expensive,” said Mackay, who is a lead on the clinical trial. “Finding lower cost alternatives that maintain the health of people would be fantastic.”

Researchers will screen about 1,500 people to find under 200 people with biomarkers to be eligible for the study.

The third aim will look at the experience of First Nations people as they progress through the clinical trial from start to finish. Amanda Fowler-Woods, a PhD candidate in the department of community health sciences, Max Rady College of Medicine, said that there have been clinical trials done with Indigenous people before but this would be the first-ever study to gather their experiences.

“We want to know if Indigenous peoples are feeling like research is still not being done in a good way, because if you look at history, that makes perfect sense,” said Fowler-Woods, who is a lead on the third aim. “Our peoples weren’t treated well. Scientific experiments were done on Indigenous peoples, not with them. And the results of that have been traumatic, so this is an opportunity to actually get constant feedback on what we are doing good, and what we are not doing good on.”

Fowler-Woods said that this is also a chance to build a framework for how to combine Indigenous methodologies with quantitative research so scientists are not only doing research with First Nations people but they’re taking care of their spirits, and protecting and honouring who they are.

“It excites me that the communities will feel respected, and they’ll start to see that there’s a possibility that research is actually working to help,” Fowler-Woods said.

El-Gabalawy said that one of the things that thrills him about this project is that it brings seasoned scientists – like Dr. Aaron Marshall, head of the department of immunology, Dr. John Wilkins, professor of internal medicine and director of the Manitoba Centre for Proteomics and Systems Biology, and Dr. Neeloffer Mookherjee, associate professor within the departments of internal medicine and immunology – together with up-and-comers like Fowler-Woods, Mackay, Dr. Liam O’Neil, assistant professor of internal medicine, and Dr. Vidyanand Anaparti, a post-doctoral fellow in the Max Rady College of Medicine.

“I’m excited because this project leverages lots of different expertise at the University of Manitoba,” Mackay said. “I’m glad that CIHR recognized that and funded the project.”

In fact, unlike in adults, where other types of socioeconomic disadvantage influence the health gap, income level alone can predict 16 out of 19 types of health inequality in Manitoba children.

These findings are revealed by a new study funded by the Children’s Hospital Research Institute of Manitoba (CHRIM). Investigators from CHRIM collaborated on the project with scientists from the Manitoba Centre for Health Policy (MCHP) at the University of Manitoba.

The study of health data, published in the journal Pediatric Research, aimed to evaluate how strongly various measures of socioeconomic status are associated with poorer health in infants, children and teens.

“We know that in general, factors such as poverty, unstable housing and living in a neighbourhood with a low average level of education are linked with poorer health,” said the study’s lead author, Dr. Atul Sharma, assistant professor of pediatrics and child health at the U of M’s Max Rady College of Medicine and researcher at CHRIM.

“But scientists who analyze data to understand what forms of deprivation and marginalization are associated with what health problems usually focus on adults. Few studies have looked at children.”    

Research tools called “area-based socioeconomic measures” (ABSMs) are based on Canadian census data, broken down by postal code. Researchers have developed various ABSMs by combining different types of data for each neighbourhood, such as average household income, the unemployment rate, high school completion rate and the number of single-parent families.

Sharma’s study is the first to compare a number of Canadian ABSMs to see how well they predict the health gaps experienced by children.

Sharma teamed with CHRIM colleagues Dr. Celia Rodd, professor of pediatrics and child health, and Dr. Marni Brownell, professor of community health sciences, as well as with Dr. Dan Chateau, assistant professor of community health sciences, and Kristine Kroeker, data analyst at the George and Fay Yee Centre for Healthcare Innovation. Brownell and Chateau are research scientists at MCHP.

The researchers tested the measurement tools by using anonymized health data stored in the Manitoba Population Research Data Repository at MCHP. They analyzed Manitoba children’s health by neighbourhood in the period 2010 to 2015.   

“Being able to link census data with individual health data for the entire Manitoba population highlights the unique research capability of the MCHP data repository,” said Chateau. “It can give us a full picture of gaps and the impacts of the social determinants of health.”

The health “outcomes” that were analyzed included rates of early experiences such as premature birth, low birth weight and breastfeeding; rates of infant and neonatal mortality; rates of completing recommended childhood vaccines; and rates of childhood hospitalization and teen pregnancy.   

The study revealed significant inequalities based on neighbourhood socioeconomic status in 19 of the 20 health outcomes that were studied. Income level alone predicted 16 of these 19 inequalities.

Among children in Manitoba’s lowest-income neighbourhoods, for example, the infant mortality rate was more than double, hospitalizations were more than double, and the teen pregnancy rate was more than 10 times higher, compared to the highest-income neighbourhoods.

“In adults, it’s been found that more nuanced, multidimensional indexes – not just income – are needed to capture the relationships between socioeconomic status and health outcomes,” said Sharma. “We thought the same would be true for children. We were surprised that income level alone was so strongly associated with health disadvantages in kids and teens.

“Our finding that some area-based measurement tools are not effective for predicting children’s health is important because it shows that neighbourhood factors that play a role in adults’ health are not necessarily correlated with children’s health.”

The study concludes that poverty is a strong driver of health inequality among Manitoba’s children, and recommends that this evidence be used by health-care policymakers.

A Manitoba clinical trial will test that idea by asking people with the disease to mix a flavourless powdered supplement into a drink, such as a smoothie, each day.

Dr. Dylan MacKay, assistant professor of community health sciences at the University of Manitoba and clinical trialist at the George and Fay Yee Centre for Healthcare Innovation (a partnership between the U of M and the Winnipeg Regional Health Authority), is leading the study.

His co-investigators are Dr. Rebecca Mollard, adjunct professor of food and human nutritional sciences, and Dr. Navdeep Tangri, associate professor of internal medicine, both affiliated with the Chronic Disease Innovation Centre at Seven Oaks General Hospital.

“Prebiotic supplements that improve the gut microbiome – the bacteria in the gut – have health- improving potential,” said MacKay, a nutritional biochemist.

“We know that ‘resistant starch,’ which is abundant in uncooked potatoes and unripe bananas, passes through the upper intestine without being digested and is a source of food for the gut microbiome when it reaches the lower intestine. Now we want to evaluate its potential in chronic kidney disease.”   

Participants in the clinical trial won’t know if they’ve received the resistant potato starch or a placebo: a digestible starch powder.

Chronic kidney disease affects about 10 per cent of Canadian adults. Manitoba’s rate, the highest of any province, is about 14 per cent. Although kidney dialysis can extend the lifespan of those with kidney failure, affordable new treatments are needed to delay or prevent this final stage of the disease.

“In chronic kidney disease, the kidneys lose their ability to manage substances called uremic toxins,” MacKay said. “The toxins accumulate, eventually leading to the patient needing dialysis. Many of these toxins originate from bacteria that live inside us.

“By changing the food source of these bacteria through resistant starch consumption, we may be able to reduce toxin production. This could potentially delay the progression to dialysis and/or reduce symptoms associated with the elevated toxins, such as nausea, fatigue and itchy skin.”

A Manitoba company, MSPrebiotic, is providing the supplement for the study. Based in Carberry, Man., the company produces supplement-grade resistant starch from peeled, dried potatoes. “We’re thrilled to be supporting world-class research at the University of Manitoba and the Chronic Disease Innovation Centre,” said Dr. Jason Bush, senior scientist at MSPrebiotic.

The study has funding from The W. Garfield Weston Foundation through its Weston Family Microbiome Initiative. “This project has the potential to advance microbiome science and healthy outcomes in a significant way,” said Mark Mitchell, chair of the initiative.

The researchers will soon start recruiting participants with chronic kidney disease for the 14-week clinical trial. If positive health effects are seen in participants who consumed the resistant potato starch, MacKay expects the study to be expanded to other centres.

The Winnipeg Foundation’s Martha Donovan Leadership Fund is a $250,000 scholarship fund created to provide leadership development opportunities for women in the Rady Faculty of Health Sciences by supporting leadership training. This year’s inaugural recipients come from the Max Rady College of Medicine, the College of Nursing and the College of Pharmacy.

Dr. Sara Israels

Dr. Sara Israels, vice-dean, academic affairs, Rady Faculty of Health Sciences, noted there were 34 applications from highly accomplished women at all stages of career development.

“I was impressed by the commitment of the applicants to enhancing their own knowledge and expertise, and to leadership goals that will benefit both the university and the community,” said Israels. “This year’s awardees exemplify the leadership potential among the women in the Rady Faculty of Health Sciences, and this bodes well for closing the leadership gender gap that presently exists in many academic and health-care institutions.”

Awardee Emily Hyde, a Master’s student in the College of Nursing, will participate in two programs from the Asper School of Business Executive Education Program.

“By using a feminist lens in the leadership training, I will explore how gender intersects with negotiation and consensus building and conflict management. The courses will help me learn practical strategies which will ultimately lead to improved productivity, job satisfaction and greater overall success for me, members of an inter-professional health care team, and most importantly, the patients.”

Dr. Amani Hamad, who recently completed her PhD degree at the College of Pharmacy and is starting postdoctoral training at the George & Fay Yee Centre for Healthcare Innovation, will attend an executive leadership program at McGill University. She says the funding will help solidify her skills and prepare her to be a leader in the highly competitive field of academia.

“I hope to use the skills I learn in the program to lead a multidisciplinary team of researchers and students who will contribute to the success of our research program and achieve their academic and research goals.”

Faculty member Dr. Michelle Driedger, a professor and director of the graduate program in the Max Rady College of Medicine’s department of community health sciences, will attend leadership training workshops delivered by the nationally recognized WinSETT Centre (the Canadian Centre for Women in Science, Engineering, Trades and Technology).

“The partnership between the Winnipeg Foundation’s Martha Donovan Fund and the Rady Faculty to support access to leadership training for women speaks to the challenges many women face in getting appropriate training and mentorship and to feel confident in taking up leadership opportunities when they arise. It just wouldn’t be possible for me to do this program without the support of the Martha Donovan Award,” she said.

The scholarships, supported by The Martha Donovan Fund held at The Winnipeg Foundation, are open to women within the Rady Faculty who are full-time academic faculty members or students/post-doctoral trainees. For the next five years, $50,000 in awards will be made available on an annual basis.

Recipients:

Faculty

• Trina Arnold, College of Nursing
• Versha Banerji, Department of Internal Medicine, Max Rady College of Medicine
• Michelle Driedger, Department of Community Health Sciences, Max Rady College of Medicine

Students/Trainees

• Alysa Almojeula, Department of Surgery, Max Rady College of Medicine
• Kaitlin Edwards, Department of Surgery, Max Rady College of Medicine
• Amani Hamad, College of Pharmacy
• Emily Hyde, College of Nursing
• Donica Janzen, College of Pharmacy
• Sarah Lesperance, Department of Community Health Sciences, Max Rady College of Medicine
• Kaye Amira Quizon, Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine
• Janine Reid, Department of Internal Medicine, Max Rady College of Medicine
• Krystal Thorington, Department of Psychiatry, Max Rady College of Medicine

The $4.3 million renovation gives students and faculty in the Rady Faculty of Health Sciences a modern facility boasting high fidelity screens, 3D capabilities and interactive tools from which to learn the intricacies of the human body.

The renovation project was kickstarted by a $500,000 donation from Dr. George Yee, who donated the money to the project before he passed away in 2014. The 1960 MD alumnus was a celebrated pathologist and philanthropist.

Dr. Brian Postl, dean of the Rady Faculty of Health Sciences, said the project was prompted by Yee’s donation, which led the Rady Faculty to find ways to raise additional funds to build the world-class facility.

“We are extremely thankful for the generosity of Dr. George and Fay Yee. Dr. Yee was a remarkable gentleman,” Postl said. “This is a wonderful facility to be named after him.”

(From left to right) Dr. Brian Postl, Dr. Charles Yee, Dr. Lauren Yee, Charlotte Tan and Dr. Thomas Klonisch.

George Yee’s son, Dr. Charles Yee, his daughter, Dr. Lauren Yee, and his granddaughter, Charlotte Tan, attended the opening event.

“My dad was very grateful for the opportunity that this institution provided him,” Charles Yee said. “The University of Manitoba Faculty of Medicine opened his eyes to the world and I’m glad to see after today, touring the cutting-edge technology of this centre, that this tradition continues.”

Dr. Thomas Klonisch, head of the department of human anatomy and cell science, spearheaded the project to replace the dated gross anatomy lab, used primarily by medical students.

The new laboratory, located in the basement of the Basic Medical Sciences Building, is bright and spacious. There are three large rooms, lined with windows and glass doors that gives the space a wide-open feeling.

The lab, which will be used by hundreds of students each year from all five of the Rady Faculty of Health Sciences’ colleges, is equipped with a powerful ventilation system and a cutting edge

TVs throughout the laboratory can display specimen, videos or presentations.

audio visual system. TVs throughout the laboratory can display specimen, videos or presentations. There are also large touchscreens that students can use to navigate 3D anatomy modelling programs.

One of the areas is equipped with surgical operating room lights. Klonisch said that they can shoot video of a dissection taking place in the lab and show it live in a lecture theatre to students.

“It’s an enormous transformation,” Klonisch said. “We’ve entered the 21^st century with this architectural marvel symbolizing the importance of what we do.”

The former gross anatomy lab space was more than 40 years old, Klonisch said, and had leaky taps, old equipment and hadn’t been updated in decades.

Klonisch said the U of M is one of only two Canadian universities where anatomy facilities have been completely revamped in recent years. With the renovated lab, he said it allows the

The lab includes large touchscreens that students can use to navigate 3D anatomy modelling programs.

university to expand anatomy courses and collaborations with clinical departments, host national meetings and provide companies with adequate space to present new surgical tools.

The Yees have a long history of philanthropy at the University of Manitoba. In 2008, Dr. George and Fay Yee provided a $2.5 million gift to establish the George & Fay Yee Centre for Healthcare Innovation at the U of M, a place that fosters interdisciplinary research and collaboration that has resulted in new ways to improve patient care and safety. It is now a more than $20-million enterprise in partnership with the WRHA.

“George Yee’s dedication to his alma mater is extraordinary,” Postl said. He matched his classmates’ gifts to the University of Manitoba Class of 1960 Entrance Scholarship in Medicine. To honour his parents’ memory, he established the Charles and Pauline Yee Bursary in Medicine at the University of Manitoba.

In total, George and Fay Yee have contributed more than $3.3 million to the University of Manitoba, illustrating a commitment to Yee’s alma mater, medical education and medical student support.

The new fund is part of the $30 million gift made in 2016 by philanthropists Ernest and Evelyn Rady in support of health sciences at the university.  

The fund will allocate a total of $1 million over three years to support collaborative research by faculty members. The one-year grants are designed to seed innovative, short-term research projects that are interdisciplinary, bringing together researchers from various departments and colleges of the Rady Faculty of Health Sciences.

“The three leading-edge projects chosen for funding in this first year combine the knowledge and skills of some of our foremost researchers,” said Dr. Peter Nickerson, vice-dean research of the Rady Faculty.  

“The Rady Innovation Fund is intended to develop research to the point where projects are well-positioned to receive external funding. These projects are likely to secure federal grants once the initial results are obtained.” 

Dr. Brian Postl, dean of the Rady Faculty of Health Sciences and vice-provost (health sciences), congratulated the winners of the inaugural funding competition. “It’s exciting to see the Rady investment driving interdisciplinary research,” he said. “These studies have the potential to directly benefit patients in the vital areas of brain health and chronic disease.” 

A team led by Dr. Thomas Klonisch, head of the department of human anatomy and cell science in the Max Rady College of Medicine, will focus on “pseudo-progression” of glioblastoma, a common brain tumor. In some cases, what appears to be growth of a brain tumor is actually treatment-induced swelling or inflammation.

If doctors fail to recognize that chemotherapy and radiation have caused the apparent worsening of the tumor, they may prematurely stop effective therapy, perform unnecessary surgery or administer more therapy than needed. And because the swelling goes down spontaneously, doctors may misinterpret the effectiveness of additional treatment.   

The team includes professors from radiology, neuro-oncology, neurosurgery, human anatomy/cell science and pharmacology/therapeutics. They will apply new, advanced diagnostic imaging techniques to identify pseudo-progression and examine whether cancer treatments change proteins in cancer cells and thereby cause tumors to swell. They will also look at whether a blood test could be used to detect pseudo-progression.

A study led by Dr. James Nagy, professor of physiology and pathophysiology, will look at communication between neurons in the hippocampus, part of the brain that plays a critical role in forming and retrieving memories. Nagy’s team includes faculty from oral biology (College of Dentistry), pharmacology/therapeutics and physiology/pathophysiology.

The function of electrical (as opposed to chemical) neurotransmission in mammals’ brains has only recently been recognized. Nagy’s team will study “mixed synapses” that transmit information both electrically and chemically.

By manipulating certain mixed synapses in the hippocampus of animal subjects, the team aims to demonstrate for the first time that electrical transmission at these synapses has a functional impact on learning and memory in mammals.

Dr. Kate Sibley, assistant professor of community health sciences and Canada Research Chair in integrated knowledge translation in rehabilitation sciences, will lead a large study team.

It includes faculty from the College of Rehabilitation Sciences (departments of physical and occupational therapy), College of Nursing and Max Rady College of Medicine (departments of community health sciences and family medicine), the Manitoba Centre for Health Policy, the George and Fay Yee Centre for Healthcare Innovation, and partners from the Winnipeg Regional Health Authority and Shared Health Services Manitoba.

This team will examine the current delivery of Winnipeg rehabilitation services (such as physiotherapy and occupational therapy) in community and home-care settings.

The team will then develop a framework for community-based “restorative care,” aiming to help people function as well as possible and stay at home as they age and live with chronic disease. This framework can be used by health-care planners in developing policy, service delivery and research. 

VIEW FULL PROJECT DESCRIPTIONS.